• ABOUT US
• PRODUCTS
• TEST MENU
• APPLICATION NOTES
• PARTNERS
• SUPPORT
• NEWS & EVENTS

Spartan Bioscience honoured for business vision

Momentum continues to build as Spartan receives accolades and industry recognition

Ottawa, ON, November 25, 2008 – Spartan Bioscience Inc., a Canadian molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications, today announced they have received the Ottawa Chamber of Commerce Ottawa Business Achievement Awards Small Business of the Year Gold Award, and were included in the Canadian Angel Capital Top 10 Companies as selected by Canadian angel investors.

“We’re honoured to be recognized by our own business community here in Ottawa and also by the Canadian angel investment community, and to have these two events happen within the same week is extremely exciting for everyone at Spartan,” said Dr. Paul Lem, CEO and Founder, Spartan Bioscience. “In today’s economic climate, it’s very gratifying to be invited and recognized by the National Angel Capital Organization for our groundbreaking work in developing on-demand DNA analyzers”.

The Ottawa Business Achievement Awards is an annual celebration of the best of the best that the Ottawa business community has to offer. Nominees vie for bronze, silver and gold awards in six separate categories. This program is sponsored of the Ottawa Chamber of Commerce.

Angel investors attending the First Canadian Co-investment Summit voted for the Canadian Angel Capital Top 10 Companies. These enterprises were considered “Canada’s best angel-backed early-stage investment opportunities by the more than 120 investors present at the summit.

“This is really a vote of confidence in the future by Canada’s Angel investors,” said W. Daniel Mothersill, President, National Angel Capital Organization. “Angel investors are the only distinct class of capital left that is focused on funding commercialization by early-stage companies – our investees are Canada’s future champions and major employers.”

About Spartan Bioscience

Founded in 2005, Spartan Bioscience Inc. is a privately-held molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications. The company is focusing on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.

-30-

For Media and Analyst inquiries, please contact:

Shelley Mullins
Media and Analyst Relations
Spartan Bioscience Inc.
Shelley.mullins@spartanbio.com
613-866-8803

Canadian Angel Capital Top 10 Companies Recognized

Co-investment Summit Showcases Tomorrow’s Champions

TORONTO, Nov. 20 /CNW/ - Angel investors attending the First Canadian Co-investment Summit yesterday from across Canada voted for the Canadian Angel Capital Top 10 Companies. These enterprises were considered “Canada’s best Angel-backed early-stage investment opportunities” by the over 120 investors present at the Summit.  “This is really a vote of confidence in the future by Canada’s Angel investors,” said W. Daniel Mothersill, President, National Angel Capital Organization. “Angel investors are the only distinct class of capital left that is focused on funding commercialization by early-stage companies - our investees are Canada’s future champions and major employers.”

The Canadian Angel Capital Top 10 Companies are:

Spartan CEO speaks at the the First Canadian Co-investment Summit (CNW Group/National Angel Capital Organization)	The National Angel Capital Organization presents a Canadian Angel Capital Top 10 Award to Dr. Paul Lem, CEO of Spartan Bioscience. Awards were the result of balloting by the investors attending the First Canadian Co-investment Summit. (CNW Group/National Angel Capital Organization)